• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
SEI Investments Company - Common Stock
Sharps Compliance Corp. - Common Stock
SpringBig Holdings, Inc. - Common Stock
Edit Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Checkmate Pharmaceuticals, Inc. - Common Stock (NQ:CMPI)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, May 27, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 10.48 (51)
Ask (Size) 10.50 (12)
Prev. Close 10.50
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 22,038,218
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
CHECKMATE PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Checkmate Pharmaceuticals, Inc. - CMPI
May 17, 2022
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
CHECKMATE PHARMACEUTICALS INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Checkmate Pharmaceuticals, Inc. - CMPI
May 05, 2022
From Kahn Swick & Foti, LLC
Via Business Wire

Performance

More News

Read More
News headline image
The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More ↗
April 24, 2022
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2022 ↗
April 20, 2022
Via Benzinga
News headline image
Mid-Afternoon Market Update: Nasdaq Surges 200 Points; Dentsply Sirona Shares Plunge ↗
April 19, 2022
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
April 19, 2022
Via Benzinga
News headline image
54 Biggest Movers From Yesterday ↗
April 20, 2022
Via Benzinga
News headline image
Why Is Arqit Quantum (ARQQ) Stock Down Today? ↗
April 19, 2022
Via InvestorPlace
News headline image
Dow Up Over 400 Points as Wall Street Pores Over Earnings ↗
April 19, 2022
Via Talk Markets
News headline image
Why Is Checkmate Pharmaceuticals (CMPI) Stock Up 300% Today? ↗
April 19, 2022
Via InvestorPlace
News headline image
Mid-Day Market Update: Crud Oil Down Over 5%; Checkmate Pharmaceuticals Shares Spike Higher ↗
April 19, 2022
Via Benzinga
News headline image
38 Stocks Moving In Tuesday's Mid-Day Session ↗
April 19, 2022
Via Benzinga
News headline image
Mid-Morning Market Update: Markets Open Higher; Dow Jumps 400 Points ↗
April 19, 2022
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
April 19, 2022
Via Benzinga
News headline image
The Daily Biotech Pulse: Regeneron Acquires Checkmate Pharma, Moderna's Bivalent Booster COVID-19 Vaccine Update, Priority Review For AstraZeneca's Enhertu ↗
April 19, 2022
Via Benzinga
News headline image
Checkmate Pharma Shares Skyrocket Over 300% On Regeneron $250M Acquisition Deal ↗
April 19, 2022
Via Benzinga
News headline image
Why Checkmate Pharmaceuticals Shares Are Skyrocketing ↗
April 19, 2022
Via Benzinga
News headline image
CMPI Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Checkmate Pharmaceuticals, Inc. Is Fair to Shareholders
April 19, 2022
From Halper Sadeh LLP
Via Business Wire
News headline image
The Daily Biotech Pulse: Aeglea Stock Jumps On Inherited Metabolic Disease Data, Partial Hold Lifted On Gilead's 2 Blood Trials, Early Data From Novartis' KRAS Inhibitor And More ↗
April 12, 2022
Via Benzinga
News headline image
The Week Ahead In Biotech (April 10-April 16): Regeneron FDA Decision, Cancer Conference Presentations And More ↗
April 10, 2022
Via Benzinga
News headline image
60 Biggest Movers From Yesterday ↗
February 10, 2022
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
December 15, 2021
Via Benzinga
News headline image
The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares ↗
November 12, 2021
Via Benzinga
News headline image
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More ↗
November 08, 2021
Via Benzinga
News headline image
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More ↗
October 24, 2021
Via Benzinga

Frequently Asked Questions

Is Checkmate Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Checkmate Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Checkmate Pharmaceuticals, Inc. - Common Stock trade on?
Checkmate Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Checkmate Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Checkmate Pharmaceuticals, Inc. - Common Stock is CMPI on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap